BMGP holds revolutionary patented technologies that can potentially re-vitalize the diagnostics industry!
Worldwide the industry is said to be worth $21 billion!
BMGP's first product that is being readied for market is the High Throughput Screening - Magnetic Testing Platform (HTS-MTP).
BMGP has designed their first products that will offer their customers a confirmatory test at the same price their competitors currently charge for a screening test, which provides far less accuracy.
BMGP's High Throughput Screening - Magnetic Testing Platform (HTS-MTP) technology is designed to detect the virus and count the viral load in a matter of minutes.
No other screening, or confirmatory test, has the ability to measure viral load, a critical measurement in developing drugs and vaccines!!
What makes BMGP's test unique is that no current single diagnostic system offers the capability of using any body fluid like saliva, urine, tear drops, spinal fluid, semen, hormonal fluid, etc.
BMGP accomplishes this through the use of proprietary electronics, and chemistry which include specially designed sensors, which will detect paramagnetic-microspheres coated with specific antibodies, and will bind to any antigen (or other specified target) within the sample. Specific software programs will be designed for each type of pathogenic assay.
There is a strong demand for diagnostic tests and companies like BMGP!
BMGP is continuing formal negotiations to purchase an interest in Tianjin Automatic Science & Instrument Co. LTD.
BMGP will gain access to over 1,250 distributors, a laboratory client base of 10,000 and skilled manufacturing in the business community’s most exciting markets, by acquiring an interest in Tianjin Auto Science!
BMGP has a continued commitment to early detection and decreasing widespread disease.
BMGP efforts will focus upon conducting clinical trials and product registrations, not just in the United States but in Mexico, Thailand, China and Sweden (Sweden will register our products throughout Europe) as well.
Upon completion of clinical trials in Latin America and Asia, BMGP will initiate a 510K registration with the U.S. Food and Drug Administration (F.D.A).
BMGP offers the medical industry a unique method that provides confirmatory and viral load diagnostics at the same cost of screening assays. The HTS-MTP will detect any virus or bacteria and count the viral load in a matter of minutes and has the capabilities of screening several hundred percent more assays / hour at a fraction of the cost of current technologies.
For more information on BMGP, please visit:
Welcome to Biomagnetics Diagnostics Corporation.